Quotes 5-day view Delayed Xetra
05/16/2022
05/17/2022
05/18/2022
05/19/2022
05/20/2022
Date
324(c)
322.5(c)
313(c)
320(c)
317
Last
3 729
1 709
3 537
2 180
2 217
Volume
+6.58%
-0.46%
-2.95%
+2.24%
-0.94%
Change
Estimated financial data (e) EUR USD
Sales 2022
4 139 M
4 382 M
4 382 M
Net income 2022
574 M
608 M
608 M
Net Debt 2022
1 457 M
1 543 M
1 543 M
P/E ratio 2022
35,8x
Yield 2022
0,37%
Sales 2023
4 512 M
4 777 M
4 777 M
Net income 2023
642 M
680 M
680 M
Net Debt 2023
1 011 M
1 071 M
1 071 M
P/E ratio 2023
33,9x
Yield 2023
0,37%
Capitalization
22 519 M
23 842 M
23 842 M
EV / Sales 2022
5,79x
EV / Sales 2023
5,21x
Nbr of Employees
15 051
Free-Float
33,3%
Sartorius AG specializes in the design, manufacturing and marketing of medical equipments for the pharmaceutical, chemical and food processing industries. The group also develops mechatronic instruments for industrial and laboratory applications. Net sales break down by family of products as follows:
- biotechnological equipments (76.3%): fermentation, filtration, process, membrane chromatography and fluids storage...
All news about SARTORIUS AG
News in other languages on SARTORIUS AG
Analyst Recommendations on SARTORIUS AG
SARTORIUS AG - 2021
No turn-around in sight
BUY
Porsche, Puma to join Germany's DAX as index expands
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SARTORIUS AG
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
320,00 €
Average target price
443,55 €
Spread / Average Target
38,6%
Please enable JavaScript in your browser's settings to use dynamic charts.